Qiuyu Cao

Qiuyu Cao

Auto-generated profile, based on publicly available information

Qiuyu Cao

Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Rui Jin 2nd Road, Shanghai 200025, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 May 2024 in Journal of the American Heart Association
Verified
Journal Article
Open access
QCQiuyu Cao
Qiuyu Cao
YBYufang Bi
Yufang Bi
FAFlor Alvarado
Flor Alvarado
AAAmanda H. Anderson
Amanda H. Anderson
KMKatherine Teresa Mills
Katherine Teresa Mills
MUMark L. Unruh
Mark L. Unruh
Background: Higher cardiovascular health (CVH) score is associated with lower risks of cardiovascular disease (CVD) and mortality in the general population. However, it is unclear whether cumulative CVH is associated with CVD, end‐stage kidney disease (ESKD), and death in patients with chronic kidney disease. Methods and Results: Among individuals from the prospective CRIC (Chronic Renal Insufficiency Cohort) Study, we used the percentage of the maximum possible CVH score attained from baseline to the year 5 visit to calculate cumulative CVH score. Multivariable‐adjusted Cox proportional hazards regression was used to investigate the associations of cumulative CVH with risks of adjudicated CVD (myocardial infarction, stroke, and heart failure), ESKD, and all‐cause mortality. A total of 3939 participants (mean age, 57.7 years; 54.9% men) were included. The mean (SD) cumulative CVH score attained during 5 years was 55.5% (12.3%). Over a subsequent median 10.2‐year follow‐up, 597 participants developed CVD, 656 had ESKD, and 1324 died. A higher cumulative CVH score was significantly associated with lower risks of CVD, ESKD, and mortality, independent of the CVH score at year 5. Multivariable‐adjusted hazard ratios and 95% CIs per 10% higher cumulative CVH score during 5 years were 0.81 (0.69–0.95) for CVD, 0.82 (0.70–0.97) for ESKD, and 0.80 (0.72–0.89) for mortality. Conclusions: Among patients with chronic kidney disease stages 2 to 4, a better CVH status maintained throughout 5 years is associated with lower risks of CVD, ESKD, and all‐cause mortality. The findings support the need for interventions to maintain ideal CVH status for prevention of adverse outcomes in the population with chronic kidney disease.

9 July 2026 in European Heart Journal
Verified
Journal Article
Closed access
QCQiuyu Cao
Qiuyu Cao
XXXingkun Xu
Xingkun Xu
HLHong Lin
Hong Lin
YYYue Yin
Yue Yin
SWShengli Wu
Shengli Wu
JLJieli Lu
Jieli Lu
Traditional Cox proportional hazards models show suboptimal performance for cardiovascular disease (CVD) risk prediction in Chinese populations. Transformer-based deep learning models have demonstrated promise in clinical risk prediction. In this study, sex-specific transformer-based models (China-AIHeart) for 10-year CVD risk prediction among Chinese adults were developed and validated. The derivation cohort included 156 790 participants [34.6% men; mean [SD] age, 56.7 [8.9] years) without CVD from the China Cardiometabolic Disease and Cancer Cohort. External validation was conducted in two independent Chinese cohorts (Xinjiang and CHARLS). Transformer-based time-to-event prediction models were developed, including a full model (22 predictors) and a simplified model (15 predictors). Performance was compared with Cox models using identical predictors and established risk scores (China-PAR, PREVENT-ASCVD, and SCORE2 Asia-Pacific equations). China-AIHeart demonstrated good discrimination (C-statistic [95% confidence interval, CI]: .767 [.754-.779] in men; .780 [.769-.791] in women), calibration (calibration χ2: 14.806 in men; 9.326 in women; Brier score: .104 in men; .077 in women), and net clinical benefit in predicting CVD risk. Predicted event rates closely matched observed risks across strata. Compared with Cox models with identical predictors, China-AIHeart showed improved discrimination (ΔC-statistic [95% CI]: .027 [.025-.028] in men; .031 [.029-.033] in women) and reclassification (net reclassification index [95% CI]: .478 [.466-.492] in men; .560 [.551-.572] in women), and outperformed China-PAR, PREVENT-ASCVD, and SCORE2 Asia-Pacific equations. External validation demonstrated robust performance, with C-statistics of .781/.825 (men/women) and .748/.820 for the full and simplified models in the Xinjiang cohort, and .740/.771 for the simplified model in the CHARLS cohort. The transformer-based China-AIHeart models predicted 10-year CVD risk and outperformed traditional Cox-based approaches, providing a practical tool for risk stratification in Chinese adults.

23 October 2020 in Medicine
Verified
Journal Article
Open access
ZXZhuoting Xie
Zhuoting Xie
Yin LiYin Li
Yin Li
ZCZehua Chen
Zehua Chen
QCQiuyu Cao
Qiuyu Cao
CZChunren Zhang
Chunren Zhang
YGYongge Guan
Yongge Guan
Background: Decreased ovarian reserve (DOR) is a common reproductive barrier in female. Bushen Huoxue (BSHX) method of TCM is widely applied to treat DOR clinically. The purpose of this study is to provide a systemic and comprehensive evaluation of BSHX in the treatment of DOR. Methods: We have registered this protocol with OSF registry and the DOI is 10.17605/OSF.IO/QNUE2. We will search 4 English databases (PubMed, EMBASE, MEDLINE, Cochrane Library) and four Chinese databases (China national knowledge infrastructure database, Wanfang database, VIP and Superstar database) from their inception to August 10, 2020. Two authors will search and extract independently all related studies. RevMan 5.3 software will be applied to synthesize data. Results: The results of this study will be published in a scientific journal after peer-review. Conclusion: This systematic review will provide reliable evidences for clinicians, and help them make decisions in DOR management.